Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses
Background. Cardiac hypertrophy is one of the initial disorders of the cardiovascular system and can induce heart failure. Oxidative stress is an important pathophysiological mechanism of cardiac hypertrophy. Wogonin (Wog), an important flavonoid derived from the root of Scutellaria baicalensis Geor...
Saved in:
Main Authors: | Xiaowen Shi, Bin Zhang, Zhenliang Chu, Bingjiang Han, Xueping Zhang, Ping Huang, Jibo Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2021/9995342 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wogonin Attenuates Ovalbumin Antigen-Induced Neutrophilic Airway Inflammation by Inhibiting Th17 Differentiation
by: Rie Takagi, et al.
Published: (2014-01-01) -
20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca2+ signaling in H9c2 cells
by: Jingyi Han, et al.
Published: (2025-01-01) -
TRIM26 exacerbates pathological cardiac hypertrophy by activating TAK1
by: Xiaochuang Xia, et al.
Published: (2025-01-01) -
Extracellular vesicular microRNAs and cardiac hypertrophy
by: Hai Hu, et al.
Published: (2025-01-01) -
Baicalin Mitigates Cardiac Hypertrophy and Fibrosis by Inhibiting the p85a Subunit of PI3K
by: Lu He, et al.
Published: (2025-01-01)